原著論文


【2017】


121.Michio Kimura, Eiseki Usami, Mina Iwai, Hitomi Teramachi, Tomoaki Yoshimura, Severe neutropenia: a prognosticator in patients with advanced/recurrent colorectal cancer under oral trifluridine-tipiracil (TAS-102) chemotherapy, Pharmazie , 72, 49-52, 2017.

122.野口義紘,林勇汰,吉田阿希,杉田郁人,江﨑宏樹,齊藤康介,臼井一将,加藤未紗,舘知也,寺町ひとみ,高齢者において有害事象の予後が悪化する可能性がある内用医薬品の探索,医薬品情報学,18,277-283,2017.

123.田口真穂,重山昌人,伊東奈保美,小川法子,高橋知里,村田実希郎,埴岡伸光,山本浩充,寺町ひとみ,デンプン非含有Mohsペーストの調製と製剤評価,YAKUGAKU ZASSHI,137,477-484,2017.

124.Mina Iwai, Michio Kimura, Eiseki Usami, Tomoaki Yoshimura, Hitomi Teramachi, Pharmaco-economic analysis of adjuvant chemotherapy for stage II and III colorectal cancer,Mol. Clin. Oncol. , 6, 794-798, 2017.

125.Eiseki Usami, Michio Kimura, Mina Iwai, Hitomi Teramachi, Tomoaki Yoshimura, Analysis of the incidence of tumor lysis syndrome in patients with hematological malignancies treated with rasburicase,Mol. Clin. Oncol. , 6, 955-959, 2017.

126.Tomoko Matsuoka, Misa Kato, Yasutaka Shinoda, Kengo Ohashi, Shinya Yoshida, Takayuki Mori, Tomoya Tachi, Tomoaki Yoshimura, Hitomi Teramachi, Evaluation of antimicrobial stewardship (AS) for appropriate use of antimicrobial agents, Pharmazie ,72, 296-299, 2017.

127.Kazumasa Usui, Hiromi Mori, Tomoya Tachi, Tomohiro Matsumura, Koki Mori, Ako Takeda, Yoshihiro Noguchi, Tomoaki Yoshimura, Hitomi Teramachi, A rapid method to screen poisoning causative agents in an acute care hospital in Japan, J. Clin. Pharm. Ther. 42, 454-460, 2017.

128.Takayuki Seko, Tomoya Tachi, Naoki Kawashima, Teruo Maeda, Minako Yasuda, Yoshihiro Noguchi, Hitomi Teramachi, Economic evaluation of infection control activities, J. Hosp. Infect. , 96, 371-376. 2017.

129.Michio Kimura, Makiko Go, Mina Iwai, Eiseki Usami, Hitomi Teramachi, Tomoaki Yoshimura, Usefulness of a pharmacist outpatient service for S-1 adjuvant chemotherapy in patients with gastric cancer, Mol. Clin. Oncol., 7, 486-492,2017.

130.Michio Kimura, Makiko Go, Mina Iwai, Eiseki Usami, Hitomi Teramachi, Tomoaki Yoshimura, Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents, J. Oncol. Pharm. Pract., 23, 413-421,2017.

131.寺町ひとみ,杉田郁人,伊野陽子,林勇汰,吉田阿希,大坪愛実,上野杏莉,勝野隼人,野口義紘,井口和弘,舘知也, テキストマイニング法を用いた実務実習における学生の感想文に関する研究-コミュニケーションに注目した解析-,YAKUGAKU ZASSHI,137,1177-1187,2017.

132.松岡知子,篠田康孝,大橋健吾,吉田真也,加藤未紗,森卓之,吉村知哲,寺町ひとみ,中等度肝機能障害患者におけるカスポファンギンの安全性に関する検討,日本化学療法学会,65,597-6011,2017.

133.伊野陽子,上野杏莉,舘知也,大坪愛実,勝野隼人,杉田郁人,兼松勇汰,吉田阿希,野口義紘,堺千紘,井口和弘,川上ちひろ,藤崎和彦,寺町ひとみ, 病院および診療所における薬局との連携に関する調査,医療薬学,43,533-551,2017.

134.Tomoko Matsuoka, Shinya Yoshida, Kengo Ohashi, Yasutaka Shinoda, Misa Kato, Takayuki Mori, Tomoaki Yoshimura, Koji Tanaka, Ayako Sato, Takashi Goto, Yuko Asano, Shiomi Ishigo, Joe Shindo, Yoshinori Fujimoto, Hitomi Teramachi, Evaluation of efficacy and clinical utility of potassium peroxymonosulfate-based disinfectants, Can. J. Infect. Control, ,32,93-97,2017.

135.Satoshi Yokoyama, Satoko Yajima, Chihiro Sakai, Shuji Yamashita, Yoshihiro Noguchi, Yoko Ino, Kazuhiro Iguchi, Hitomi Teramachi, Community pharmacist–led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer, Can Pharm J (Ott) ,150,362-365,2017.

136.Hiroki Esaki, Tomoya Tachi, Chitoshi Goto, Ikuto Sugita, Yuta Kanematsu, Aki Yoshida, Kosuke Saito, Yoshihiro Noguchi, Yuki Ohno, Satoshi Aoyama, Masahiro Yasuda, Takashi Mizui, Masumi Yamamura, Hitomi Teramachi, Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus, Front. Pharmacol., 8:835. doi: 10.3389/fphar.2017.00835, 2017.

137.野口義紘,杉田郁人,林勇汰,吉田阿希,上野杏莉,大坪愛実,勝野隼人,江﨑宏樹,齊藤康介,舘知也,寺町ひとみ,安全性シグナル指標を用いた経口非ステロイド抗炎症薬の既知の有害事象である消化器障害のリスク評価とその注意点, 医薬品情報学,19,127-132,2017.

138.橋口宏司,田口真穂,菊池絵里,飯村仁美,横山敦,久保雅恵,神谷武伺,藤澤順,重山昌人,寺町ひとみ,ソルビトールの添加で塗布性を改善した新処方Mohsペーストの臨床使用の1例,日本緩和医療薬学雑誌,10,111-114,2017.